← Back to Search

"MyPlan" - Individualized Planned Eating Pattern for Type 1 Diabetes

N/A
Waitlist Available
Led By Elizabeth J Mayer-Davis, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 22-24
Awards & highlights

Summary

This trial tests a personalized meal plan called 'MyPlan' for young people with type 1 diabetes who struggle with blood sugar control. The plan involves eating meals and snacks at regular times and in specific amounts to help stabilize blood sugar levels. The study will see if this approach is acceptable and effective over several months.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 22-24
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 22-24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability Percentage (Guardian)
Acceptability Percentage (Youth)
Adherence to 0-5 Eating Behavior Goals
+6 more
Secondary study objectives
Change in Hemoglobin A1c Percentage

Trial Design

1Treatment groups
Experimental Treatment
Group I: "MyPlan" - Individualized Planned Eating PatternExperimental Treatment1 Intervention
All youth enrolled in the study will receive the 6-month MyPlan behavioral intervention. Youth and their guardian will be paired with a dietitian to individualize the eating pattern and receive support in setting and refining action plans focused on adhering to the five eating behavior goals that define the eating pattern.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
"MyPlan" - Individualized Planned Eating Pattern
2021
N/A
~60

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,410 Previous Clinical Trials
4,324,839 Total Patients Enrolled
University of CincinnatiOTHER
433 Previous Clinical Trials
636,351 Total Patients Enrolled
University of North Carolina, Chapel HillLead Sponsor
1,543 Previous Clinical Trials
4,248,990 Total Patients Enrolled
~14 spots leftby Sep 2025